mideplanin   Click here for help

GtoPdb Ligand ID: 10830

Synonyms: CTA A1 | MDL 62873 | MDL-62873 | MDL62873
Compound class: Peptide or derivative
Comment: Mideplanin is an experimental glycopeptide antibacterial, that is a semisynthetic amide derivative of teicoplanin [2].
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES OCC1OC(Oc2c3Oc4ccc(cc4Cl)C(OC4OC(CO)C(C(C4NC(=O)C)O)O)C4NC(=O)C(NC(=O)C5c(c3)cc2Oc2ccc(cc2Cl)CC2C(=O)NC(C(=O)N5)c3cc(O)cc(c3)Oc3cc(C(C(=O)N2)N)ccc3O)c2ccc(c(c2)c2c(C(NC4=O)C(=O)NCCCN(C)C)cc(cc2OC2OC(CO)C(C(C2O)O)O)O)O)C(C(C1O)O)NC(=O)CCCCCCC(C)C
Isomeric SMILES OCC1OC(Oc2c3Oc4ccc(cc4Cl)C(OC4OC(CO)C(C(C4NC(=O)C)O)O)C4NC(=O)C(NC(=O)C5c(c3)cc2Oc2ccc(cc2Cl)CC2C(=O)NC(C(=O)N5)c3cc(O)cc(c3)Oc3cc(C(C(=O)N2)N)ccc3O)c2ccc(c(c2)c2c(C(NC4=O)C(=O)NCCCN(C)C)cc(cc2OC2OC(CO)C(C(C2O)O)O)O)O)C(C(C1O)O)NC(=O)CCCCCCC(C)C
InChI InChI=1S/C93H109Cl2N11O32/c1-38(2)11-8-6-7-9-12-65(115)100-73-79(120)76(117)63(36-108)135-92(73)138-83-60-30-45-31-61(83)132-57-20-16-43(28-52(57)95)82(137-91-72(98-39(3)110)78(119)75(116)62(35-107)134-91)74-90(129)104-71(86(125)97-21-10-22-106(4)5)50-33-47(112)34-59(133-93-81(122)80(121)77(118)64(37-109)136-93)66(50)49-27-42(15-17-54(49)113)68(87(126)105-74)102-89(128)70(45)103-88(127)69-44-25-46(111)32-48(26-44)130-58-29-41(14-18-55(58)114)67(96)85(124)99-53(84(123)101-69)24-40-13-19-56(131-60)51(94)23-40/h13-20,23,25-34,38,53,62-64,67-82,91-93,107-109,111-114,116-122H,6-12,21-22,24,35-37,96H2,1-5H3,(H,97,125)(H,98,110)(H,99,124)(H,100,115)(H,101,123)(H,102,128)(H,103,127)(H,104,129)(H,105,126)
InChI Key KVZUWEFUEGGULL-UHFFFAOYSA-N
References
1. Bartoloni A, Colao MG, Orsi A, Dei R, Giganti E, Parenti F. (1990)
In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
J Antimicrob Chemother, 26 (5): 627-33. [PMID:1688341]
2. Biavasco F, Lupidi R, Varaldo PE. (1992)
In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
Antimicrob Agents Chemother, 36 (2): 331-8. [PMID:1534977]
3. Jones RN, Goldstein FW, Zhou XY. (1991)
Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.
Antimicrob Agents Chemother, 35 (3): 584-6. [PMID:1828137]